Sameer Al-Maisary, Migdat Mustafi, Gabriele Romano, Matthias Karck, Rawa Arif, Patricia Kraft, Mario Jesus Guzman-Ruvalcaba
{"title":"Age-stratified clinical phenotypes of cardiac implantable electronic device infections: a 20-year retrospective cohort study.","authors":"Sameer Al-Maisary, Migdat Mustafi, Gabriele Romano, Matthias Karck, Rawa Arif, Patricia Kraft, Mario Jesus Guzman-Ruvalcaba","doi":"10.1186/s12872-026-06736-2","DOIUrl":"10.1186/s12872-026-06736-2","url":null,"abstract":"<p><strong>Background: </strong>The widespread adoption of cardiac implantable electronic devices (CIEDs) has been accompanied by a parallel increase in severe CIED infections. Traditional risk stratification frequently relies on binary age cutoffs, which can obscure how infection phenotypes evolve across a patient's lifespan. This study evaluated how advancing age-analyzed across ordered chronological strata-correlates with anatomical infection site, device hardware type, microbiology, and in-hospital mortality in patients with CIED infections.</p><p><strong>Methods: </strong>In this retrospective cohort study of 383 patients treated for CIED infections between 2002 and 2022, patients were categorized into five sequential age brackets (< 50 to 80-90 years). Age was modeled both categorically across these strata and continuously to estimate per-decade odds ratios (ORs) for clinical presentation, hardware type, and microbiological findings.</p><p><strong>Results: </strong>The cohort was predominantly male (75.2%) with a mean age of 67.4 years. Pacemaker involvement increased significantly with age (p < 0.001), whereas implantable cardioverter-defibrillator use declined (p = 0.036). Localized generator pocket infections demonstrated a pronounced age-dependent gradient, rising from 19.4% in patients under 50 years to 73.0% in octogenarians (p < 0.001; OR 1.43 per decade, 95% CI: 1.21-1.69). Conversely, systemic presentations-including bacteremia and lead endocarditis-showed no age-dependent trend. In-hospital mortality remained low and stable across age groups (p = 0.452) but was markedly higher in patients presenting with bacteremia or sepsis compared to those without systemic involvement (16.7% vs. 1.6%, p < 0.001).</p><p><strong>Conclusions: </strong>Analyzing age as a continuous spectrum reveals a distinct clinical phenotype dominated by localized pocket infections and low-power devices, an insight obscured by standard binary age cutoffs. Crucially, mortality risk was driven by systemic bloodstream infection rather than patient age itself, emphasizing that clinical surveillance should prioritize infection phenotype over chronological age alone.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13733054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anna Damlin, Andreas Rück, Mesud Mustafic, Rebecka Jandér, Anette Rickenlund, Maria J Eriksson, Nawzad Saleh, David Marlevi
{"title":"Improvement in mitral regurgitation after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: a retrospective cohort study.","authors":"Anna Damlin, Andreas Rück, Mesud Mustafic, Rebecka Jandér, Anette Rickenlund, Maria J Eriksson, Nawzad Saleh, David Marlevi","doi":"10.1186/s12872-026-06952-w","DOIUrl":"https://doi.org/10.1186/s12872-026-06952-w","url":null,"abstract":"<p><strong>Background: </strong>The primary mechanism of mitral regurgitation (MR) in hypertrophic obstructive cardiomyopathy is systolic anterior motion (SAM) of the mitral leaflets due to septal hypertrophy narrowing the left ventricular outflow tract (LVOT), influencing leaflet movement and closure. Among patients undergoing alcohol septal ablation (ASA), the impact on- and underlying mechanism of MR remains less studied. The aim was to determine the prevalence of MR and changes in MR severity after ASA and analyze echocardiographic (ECHO) parameters associated with MR changes.</p><p><strong>Methods: </strong>All patients who underwent ASA at Karolinska University Hospital in Sweden, 2009-2021 (follow-up until 2025), were included in this retrospective cohort study. ECHO parameters were collected before ASA, at 1-year follow-up and at the latest follow-up registered. To evaluate differences in continuous values, Kruskal-Wallis test was used, and for categorical values, Fischer's exact test was used.</p><p><strong>Results: </strong>154 patients were included (mean follow-up 4.0 ± 3.9 years). 14% (n = 21) had at least moderate MR at baseline, of which 90% (n = 19) improved to mild MR or less. The patients with improved (n = 19, 12%) or unchanged (n = 128, 83%) grade of MR showed greater reduction of LVOT peak pressure gradients (improved MR: 137.5 to 4.8 mmHg, unchanged MR: 57.0 to 25.0 mmHg) between baseline and last follow-up, compared with patients with increased MR grade (n = 7, 4.5%, 57.0 to 51.0 mmHg, p = 0.003).</p><p><strong>Conclusions: </strong>Among patients with at least moderate MR before ASA, MR severity generally improved at follow-up, potentially due to septal reduction and LVOT enlargement, which may have reduced SAM.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13723101/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T Gudmundsson, P Petursson, T Råmunddal, O Angeras, A Rawshani, O Frobert, J Alfredsson, C Ekenbäck, L Henareh, K Skoglund, C Ljungman, E Bollano, M Mohammad, H Hagström, T Jernberg, D Erlinge, B Redfors, E Omerovic
{"title":"Impact of the COVID-19 pandemic on the incidence and mortality of Takotsubo syndrome in Sweden, a report from the SWEDEHEART registry.","authors":"T Gudmundsson, P Petursson, T Råmunddal, O Angeras, A Rawshani, O Frobert, J Alfredsson, C Ekenbäck, L Henareh, K Skoglund, C Ljungman, E Bollano, M Mohammad, H Hagström, T Jernberg, D Erlinge, B Redfors, E Omerovic","doi":"10.1186/s12872-026-06889-0","DOIUrl":"10.1186/s12872-026-06889-0","url":null,"abstract":"<p><strong>Introduction: </strong>Takotsubo syndrome (TTS) is often triggered by intense emotional or physical stress, with symptoms closely resembling those of acute myocardial infarction and heart failure. The COVID-19 pandemic caused unprecedented psychological, social, and economic stress, with TTS incidence and mortality either increasing or remaining stable. Previous studies have relied on single- or multicenter data, lacking the scope to provide national-level insights. This study aimed to fill the gap by investigating the incidence and outcomes of TTS across Sweden during two distinct periods: the pre-pandemic period (January 2015 to March 2020) and the pandemic period (April 2020 to December 2022).</p><p><strong>Methods: </strong>Using the nationwide Swedish Coronary Angiography and Angioplasty Registry, we assessed the incidence rate (IR) for all patients with TTS referred for coronary angiography in Sweden. We calculated incidence rate ratios (IRRs) both before and during the pandemic using quasi-Poisson regression, adjusted for age and sex. We evaluated 30-day and 1-year mortality using multivariable Cox proportional hazards regression, accounting for clustering within hospitals.</p><p><strong>Results: </strong>We identified 3,180 patients hospitalized with TTS during the study period: 69% (2,189) pre-pandemic and 31% (991) during the pandemic. The incidence of TTS was 10% lower during the pandemic compared to the pre-pandemic period (IRR 0.90, 95% CI 0.84-0.97, P = 0.008). The cohort's crude all-cause mortality rate was 2.73% at 30 days and 6.10% at 1 year, with no significant difference at 30 days (adjusted HR 1.12, 95% CI 0.69-1.78, P = 0.642) or one year (adjusted HR 1.05, 95% CI 0.75-1.46, P = 0.780). Compared with studies in other countries where incidence increased or remained unchanged, COVID-19 incidence was similar across the matching periods.</p><p><strong>Conclusions: </strong>This nationwide observational study found a lower incidence of TTS during the pandemic compared to the pre-pandemic period, while mortality rates remained unchanged. The reduced incidence of TTS in Sweden may reflect the country's comparatively milder pandemic control measures and more robust social security infrastructure relative to other nations.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13729366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kristina Stefansson, Gurdeep Chahal, Johan Hultdin, Torbjörn K Nilsson, Paul Pettersson-Pablo
{"title":"ABO blood groups in relation to biomarkers of vascular structure and function in young, healthy adults - the LBA study.","authors":"Kristina Stefansson, Gurdeep Chahal, Johan Hultdin, Torbjörn K Nilsson, Paul Pettersson-Pablo","doi":"10.1186/s12872-026-06924-0","DOIUrl":"10.1186/s12872-026-06924-0","url":null,"abstract":"<p><strong>Background: </strong>In the elderly, ABO blood groups influence the risk of cardiovascular and thrombotic events, with blood group O consistently showing a more favorable risk profile. However, whether these differences affect physiological markers of vascular structure or subclinical metabolic traits in early adulthood remains poorly studied.</p><p><strong>Methods: </strong>In this cross-sectional study, cardiovascular disease-related biomarkers in serum, measures of vascular structure and function, pulse-wave velocity (PWV), augmentation index (AIx), carotid intima-media thickness (cIMT), and ABO blood groups were assessed in a sample of young, healthy subjects aged 18-26 years.</p><p><strong>Results: </strong>No statistically significant differences in PWV, AIx, or cIMT were identified across the different ABO blood groups. Conversely, the serum biomarkers showed distinct profiles. Individuals with blood group O presented with lower plasma concentrations of von Willebrand factor (vWF) compared to all non-O carriers (0.84 kIE/L vs. non-O, 1.09 kIE/L, p < 0.05). Furthermore, blood group O carriers demonstrated significantly lower fasting plasma glucose levels (4.96 mmol/L vs. 5.02 mmol/L, p = 0.02) and a trend toward lower fasting serum insulin levels (p = 0.07).</p><p><strong>Conclusion: </strong>ABO blood groups were not associated with measures of vascular structure and function in young, healthy adults. Non-O blood groups were associated with higher vWF levels and altered glucose metabolism, suggesting that circulating cardiometabolic risk markers vary by blood group early in life.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13715086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149285341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dennis Schiffer, Boshra Afshar, Daria Grosser, Juliana Pet, Lena Schmidbauer, Maximilian Bauser, Gustavo Ramos, Valerie Boivin-Jahns, Roland Jahns, Stefan Frantz, Peter Heuschmann, Stefan Störk, Brenda Gerull, Niklas Beyersdorf, Caroline Morbach
{"title":"Heart-reactive antibody levels differentially associate with ventricular function in hereditary cardiomyopathies.","authors":"Dennis Schiffer, Boshra Afshar, Daria Grosser, Juliana Pet, Lena Schmidbauer, Maximilian Bauser, Gustavo Ramos, Valerie Boivin-Jahns, Roland Jahns, Stefan Frantz, Peter Heuschmann, Stefan Störk, Brenda Gerull, Niklas Beyersdorf, Caroline Morbach","doi":"10.1186/s12872-026-06808-3","DOIUrl":"10.1186/s12872-026-06808-3","url":null,"abstract":"<p><strong>Background: </strong>gCMP are a major cause of cardiovascular morbidity and mortality. While agonistic anti-β1-adrenergic receptor antibodies (anti-β1AR-EC<sub>II</sub>) have a recognized pathogenic role in idiopathic dilated cardiomyopathy (DCM), the relevance of HRA in gCMP remains unclear.</p><p><strong>Methods: </strong>One hundred gCMP patients with confirmed genetic variants in cardiomyopathy genes were compared with 100 age- and sex-matched healthy individuals. Antibody reactivities were quantified using bead-based flow cytometric assays against cardiac antigens: The second extracellular loop of the β1 adrenergic receptor (β1AR-EC<sub>II</sub>), Troponin I3 (TPI3), Tropomyosin 1 (TPM1), Myosin heavy chain 6 and 7 (MYH6, MYH7) and Myosin light chain 7 (MYL7).</p><p><strong>Results: </strong>gCMP patients showed higher anti-TPI3 and lower anti-TPM1 antibody levels compared to controls indicating increased induction of the former and loss of the latter in gCMP patients. Age and sex influenced HRA patterns in both groups. Anti-MYH6 and anti-TPM1 antibody levels were negatively associated with left ventricular ejection fraction (LVEF), both overall and within specific gCMP subtypes, including hypertrophic and arrhythmogenic cardiomyopathy. Additionally, anti-MYH6 antibody levels were negatively associated with right ventricular function, measured by tricuspid annular plane systolic excursion (TAPSE).</p><p><strong>Conclusion: </strong>Our findings stress the diagnostic potential of HRA profiling and indicate that gCMP patients might profit from therapeutic targeting of HRA.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13693005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149242984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammedrashid Ibraheem, Aly Abouslima, Ahmed Ebrahim, Salma Ahmed, Sara E Elbahnasawy, Mohamed Hesham Gamal, Nada Ramadan, Manar Adel, Mahmoud M Elhady
{"title":"Drug-coated balloons in coronary disease: meta-analysis comparing sirolimus- and paclitaxel-coated technologies.","authors":"Mohammedrashid Ibraheem, Aly Abouslima, Ahmed Ebrahim, Salma Ahmed, Sara E Elbahnasawy, Mohamed Hesham Gamal, Nada Ramadan, Manar Adel, Mahmoud M Elhady","doi":"10.1186/s12872-026-06811-8","DOIUrl":"10.1186/s12872-026-06811-8","url":null,"abstract":"<p><strong>Background and aim: </strong>Drug-coated balloons (DCBs) are a key alternative to drug-eluting stents for coronary artery interventions, offering the advantage of drug delivery without permanent implants. Both paclitaxel-coated balloons (PCBs) and sirolimus-coated balloons (SCBs) are valuable treatment options. This systematic review and meta-analysis compare the efficacy and safety of sirolimus-coated versus paclitaxel-coated balloon catheters in patients with coronary artery disease.</p><p><strong>Methods: </strong>We conducted a systematic review and meta-analysis following PRISMA guidelines, searching five databases. We exclusively included RCTs. Risk ratios (RR) and mean differences (MD) with 95% confidence intervals were calculated using fixed-effects or random-effects models, with sensitivity analysis performed in cases of heterogeneity.</p><p><strong>Results: </strong>Eight trials involving 1043 patients were included. The meta-analysis demonstrated no significant difference between SCB and PCB for late lumen loss (MD 0.06, 95% CI [-0.02 to 0.14]). Only two outcomes showed statistically significant differences favoring PCB: reducing late lumen enlargement (RR 0.66, 95% CI [0.49-0.87], P = 0.004) and, after sensitivity analysis, lowering binary restenosis rates in de novo lesions CONCLUSION: This meta-analysis shows SCB and PCB have similar safety and efficacy in coronary artery interventions, with no significant differences in most outcomes. However, PCB outperforms late lumen enlargement and binary restenosis rates in de novo lesions. Similar outcomes across sirolimus formulations indicate other factors influence success. Both balloon types appear safe and effective, though PCB may retain certain advantages in specific scenarios. Larger, longer-term studies are needed to establish the optimal drug-coated balloon strategy for different patient populations.</p><p><strong>Clinical trial number: </strong>not applicable.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13693106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149243003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmed Atef, Ahmed Fayed, Hemmat El-Haddad, Moataz Fathy, Heba El Deeb
{"title":"Cardio-renal dysfunction in prediabetes and early type 2 diabetes: insights from myocardial strain and renal Doppler assessment.","authors":"Ahmed Atef, Ahmed Fayed, Hemmat El-Haddad, Moataz Fathy, Heba El Deeb","doi":"10.1186/s12872-026-06661-4","DOIUrl":"10.1186/s12872-026-06661-4","url":null,"abstract":"<p><strong>Background: </strong>Prediabetes and early type 2 diabetes mellitus (T2DM) may be accompanied by subclinical cardiac and renal injury before overt disease appears. This study evaluated early cardio-renal dysfunction in prediabetes and early T2DM using myocardial strain imaging and renal Doppler assessment.</p><p><strong>Methods: </strong>This cross-sectional study included 180 participants: 60 with prediabetes, 60 with newly diagnosed T2DM (≤ 2 years), and 60 age- and sex-matched healthy controls. Conventional echocardiography and two-dimensional speckle-tracking echocardiography were used to assess left ventricular (LV) function and left atrial (LA) mechanics. Renal vascular resistance was assessed using the Doppler-derived renal resistive index (RRI) and pulsatility index (PI). Glycemic status and albuminuria were evaluated using fasting glucose, oral glucose tolerance testing, HbA1c, and urine albumin-to-creatinine ratio.</p><p><strong>Results: </strong>Compared with controls, participants with prediabetes and T2DM showed early alterations in LV relaxation/filling indices and reduced LA strain. LV ejection fraction was modestly lower, while GLS became progressively less negative across the dysglycemic groups (p < 0.001), consistent with reduced longitudinal myocardial deformation. Renal resistive index (RRI) and pulsatility index (PI) were significantly increased in the dysglycemic groups. RRI correlated positively with E/e', linking higher renal vascular resistance with higher estimated LV filling pressure (r = 0.440, p < 0.001).</p><p><strong>Conclusions: </strong>Prediabetes and early T2DM were associated with subclinical abnormalities in myocardial mechanics and renal vascular indices despite preserved conventional cardiac and renal function. Myocardial strain and renal Doppler measures may provide complementary phenotypic information, but prospective validation is required before routine clinical application.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13681910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149227304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marzia Giaccardi, Stella Cartei, Valentina Mangiafico, Maria Lucia Narducci, Roberto Scacciavillani, Marina Zampieri, Maria Luisa Loricchio, Carlos Alberto Centurión Aznaràn, Bruno Albano, Lina Marcantoni, Ambra Del Greco, Giulia Brizzi, Benito Baldauf, Gemma Pelargonio
{"title":"Prospective multicenter feasibility study of omnipolar near-field peak-frequency mapping for slow-pathway localization in typical atrioventricular nodal re-entrant tachycardia.","authors":"Marzia Giaccardi, Stella Cartei, Valentina Mangiafico, Maria Lucia Narducci, Roberto Scacciavillani, Marina Zampieri, Maria Luisa Loricchio, Carlos Alberto Centurión Aznaràn, Bruno Albano, Lina Marcantoni, Ambra Del Greco, Giulia Brizzi, Benito Baldauf, Gemma Pelargonio","doi":"10.1186/s12872-026-06779-5","DOIUrl":"https://doi.org/10.1186/s12872-026-06779-5","url":null,"abstract":"<p><strong>Background: </strong>Slow-pathway (SP) ablation is the established therapy for atrioventricular nodal re-entrant tachycardia (AVNRT). While conventional anatomical and electrogram-guided approaches are effective, SP localization may be challenging in a subset of procedures. Omnipolar near-field (OTNF) peak frequency (PF) mapping has been proposed as a signal-based approach to support SP localization; however, prospective multicenter data remain limited.</p><p><strong>Methods: </strong>Fifty consecutive adults with inducible typical AVNRT underwent catheter ablation in three Italian hospitals. High-density right atrial mapping was performed during sinus rhythm using a 16-pole grid catheter (Advisor™ HD Grid) with OTNF on the EnSite X system. PF maps were generated (high-frequency threshold > 250 Hz), and RF applications were delivered to the region of highest PF. Voltage maps were also created to delineate low-voltage bridge (LVB) regions (typically 0.04-2 mV) for retrospective overlap/localization analyses; LVB was not used to select ablation targets.</p><p><strong>Results: </strong>Acute procedural success was achieved in all patients, with no procedural complications. The effective ablation site (junctional beats with subsequent SP modification and/or non-inducibility) corresponded to the highest PF region in 45/50 patients (90%). In a retrospective overlap/localization analysis, the effective site fell within the LVB region in 36/50 patients (72%); concordance between PF-defined and LVB-defined regions at the effective site was observed in 35/50 patients (70%). Mean PF in the SP target region was 424 ± 86 Hz versus 272 ± 57 Hz in surrounding tissue (P < 0.05 on paired testing). Exploratory ROC analysis yielded an AUC of 0.937 with an optimal cutoff of 357 Hz (sensitivity 0.87; specificity 0.94); these estimates should be interpreted cautiously because PF guided RF target selection (incorporation/target-selection bias).</p><p><strong>Conclusion: </strong>In this prospective multicenter cohort, OTNF-derived PF mapping was feasible and reproducibly identified a discrete region used to guide SP ablation in typical AVNRT. ROC-derived thresholds and performance estimates are exploratory and require independent validation in cohorts where ablation targets are not selected using PF criteria.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13695299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149262833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exploratory clinical predictors and internally validated models of in-hospital mortality after PCI in obese patients with acute myocardial infarction and documented cardiogenic shock: a single-center retrospective study.","authors":"Mailidan Maimaitiniyazi, Tuersunayi Yisimitila, Muyesaier Maimaitiniyazi, Meiheliya Maisuti, Abuduwupuer Haibier, Palida Yushanjiang, Muyesai Nijiati","doi":"10.1186/s12872-026-06838-x","DOIUrl":"https://doi.org/10.1186/s12872-026-06838-x","url":null,"abstract":"<p><strong>Background: </strong>Obese patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) remain at high risk of early mortality despite percutaneous coronary intervention (PCI). Obesity and related cardiometabolic disorders may aggravate vascular and microcirculatory dysfunction, potentially involving impaired endothelial cell function. However, prognostic evidence specifically focusing on obese patients with AMI-CS undergoing PCI remains limited. This exploratory, single-center study investigated clinical factors associated with in-hospital mortality and compared the predictive performance of logistic regression and eXtreme Gradient Boosting (XGBoost) using rigorous internal validation.</p><p><strong>Methods: </strong>The archived analytic dataset contained 268 patients. After eligibility re-audit, three patients with body mass index (BMI) < 28 kg/m² were excluded, leaving 265 patients with documented AMI-CS treated with PCI. Seven routinely available candidate variables were evaluated in multivariable association and prediction analyses. Logistic regression and regularized XGBoost were compared using 20 repetitions of stratified five-fold nested cross-validation, with all model tuning confined to the inner training folds. Supplemental data on shock severity, serial lactate levels, vasoactive therapy, mechanical circulatory support, ventilation, renal replacement therapy, and hemodynamic variables were additionally evaluated descriptively and in a post hoc sensitivity analysis.</p><p><strong>Results: </strong>Among 265 patients, 202 survived and 63 died during hospitalization. Higher heart rate, hypertension, diabetes mellitus, malignant arrhythmia, and multivessel disease were associated with in-hospital mortality. The seven-variable logistic regression model achieved an area under the receiver operating characteristic curve (AUC) of 0.767 (95% CI, 0.696-0.831) and a Brier score of 0.152, compared with an AUC of 0.712 (95% CI, 0.641-0.779) and a Brier score of 0.169 for regularized XGBoost. Serial lactate concentrations at admission, peak, 6 h, 12 h, and 24 h were consistently higher in non-survivors, and cardiac power output was modestly lower. A post hoc severity-augmented logistic model achieved an AUC of 0.922 (95% CI, 0.888-0.951), but its calibration slope was 2.077, indicating that the model was not sufficiently calibrated for clinical deployment.</p><p><strong>Conclusions: </strong>In obese patients with AMI-CS undergoing PCI, heart rate, hypertension, diabetes mellitus, malignant arrhythmia, and multivessel disease were associated with in-hospital mortality. Logistic regression demonstrated more favorable internally validated predictive performance than regularized XGBoost using the same routinely available predictors. The associations of diabetes and hypertension, together with abnormalities in systemic perfusion, are biologically compatible with a potential contribution of endothelial cell dysfunction","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13695265/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149262809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparative efficacy of esophageal protection strategies during radiofrequency atrial fibrillation ablation: a systematic review and network meta-analysis of randomized trials.","authors":"Akam Ramezani, Naghmeh Kian, Amirmohammad Sharafi, Fatemeh Yousefimoghaddam, Arya Khezrpour, Amir Ghaffari Jolfayi, Arash Arya, Majid Haghjoo","doi":"10.1186/s12872-026-06836-z","DOIUrl":"10.1186/s12872-026-06836-z","url":null,"abstract":"<p><strong>Background: </strong>Esophageal thermal injury remains a clinically significant complication of radiofrequency catheter ablation for atrial fibrillation (AF), with endoscopically detected esophageal lesions (EDELs) occurring in up to 10-15% of cases and atrio-esophageal fistula carrying high mortality. Multiple protective strategies have been proposed; however, their comparative efficacy remains uncertain.</p><p><strong>Methods: </strong>We conducted a systematic review and network meta-analysis of randomized controlled trials evaluating esophageal protection strategies during AF ablation. PubMed, Web of Science, Scopus, and ClinicalTrials.gov were searched from inception through August 7, 2026. Parallel-group randomized trials in adult patients undergoing radiofrequency ablation were included. The primary outcome was incidence of EDEL. A frequentist random-effects network meta-analysis was performed, with treatment hierarchy assessed using P-scores. Risk of bias and certainty of evidence were evaluated using the Cochrane RoB 2 and CINeMA frameworks, respectively.</p><p><strong>Results: </strong>Twenty-five randomized controlled trials involving approximately 2,500 patients were included in the systematic review. Twelve trials involving 1,077 patients contributed to the connected network meta-analysis. Mechanical esophageal deviation combined with luminal esophageal temperature monitoring (LET) had the most favorable point estimate compared with no dedicated protection (OR, 0.27; 95% CI, 0.02-3.05) and achieved the highest P-score (0.861). The rankogram estimated a 58% probability of ranking first. Visualization-guided strategies also showed a favorable point estimate (OR, 0.48; 95% CI, 0.08-3.09), whereas LET alone and active cooling did not demonstrate significant reductions in EDEL. Directly, mechanical deviation plus LET significantly reduced the odds of EDEL compared with single-sensor LET (OR, 0.13; 95% CI, 0.04-0.41). Seven randomized trials involving 990 patients showed no significant association between higher- versus standard-power ablation and EDEL (OR, 1.19; 95% CI, 0.56-2.54), with no observed heterogeneity (I² = 0%). Network heterogeneity was moderate (I² = 46.9%), with no significant evidence of network inconsistency or publication bias.</p><p><strong>Conclusions: </strong>No single esophageal protection strategy completely eliminates the risk of thermal injury during AF ablation. Mechanical esophageal deviation combined with LET demonstrated the most favorable overall ranking, while visualization-guided strategies also showed a potentially beneficial signal. In contrast, LET or cooling alone did not reliably reduce EDEL incidence. However, overall confidence in the evidence is constrained by small trial samples and reliance on surrogate outcomes. Larger, contemporary trials are needed to confirm clinical benefits and assess the impact on rare but catastrophic complications.</p><p><strong>Clinical trial number: </strong>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13726319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}